Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

The study consisted of the following: * Randomization of eligible participants within 120 days of prostatectomy * For participants assigned to immediate therapy, a treatment period up to 18 months within 8 days of randomization * For participants assigned to deferred treatment, a treatment period up to 18 months after evidence of progression prior to December 2010. Participants who did not progress before December 2010 were withdrawn from the study.